{"brief_title": "APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat", "brief_summary": "The purpose of the this study is to evaluate the safety of efficacy of APC-111 775 mg MP tablet once daily dosing for 7 days for treating patients with strep throat. The evaluation will look to confirm if APC-111 eliminates the bacterial infection (Streptococcus pyogenes).", "condition": "Tonsillitis", "intervention_type": "Drug", "intervention_name": "Amoxicillin Pulsatile Release Multiparticulate Tablet (drug)", "criteria": "Inclusion Criteria: - Give informed consent, assent and patient authorization - Age 12 and over - A clinical diagnosis of acute pharyngitis or tonsillitis - A positive rapid Strep test - Can swallow the oral study dosage forms - Females must have a negative urine pregnancy test and be using acceptable birth control if sexually active Exclusion Criteria: - Chronic or recurrent odynophagia - Need for hospitalization or IV antimicrobial therapy - Pharyngitis known or suspected due to a pathogen resistant to beta-lactam antimicrobials - Known carrier of S. pyogenes - Allergies to penicillin or other beta-lactam antibiotics - Any serious illness or concomitant condition that the investigator judges will preclude inclusion to the study - Seizure disorder - Pregnant or nursing - Expectation of additional systemic antibacterials would be required for another condition - Current drug or alcohol abuse - Any experimental drug or device within the last 30 days - Prior systemic antibiotic therapy within the last 30 days - Hospitalization within the last month which included antibacterial therapy - The presence of clinically significant hematologic conditions, etc - Probenecid treatment", "gender": "All", "minimum_age": "12 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00095368.xml"}